Richard W. Paul & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $955K | Buy |
1,225
+61
| +5% | +$47.6K | 0.35% | 72 |
|
|
2025
Q1 | $961K | Buy |
1,164
+1
| +0.1% | +$826 | 0.38% | 65 |
|
|
2024
Q4 | $898K | Buy |
1,163
+136
| +13% | +$105K | 0.33% | 83 |
|
|
2024
Q3 | $910K | Sell |
1,027
-29
| -3% | -$25.7K | 0.33% | 90 |
|
|
2024
Q2 | $956K | Sell |
1,056
-38
| -3% | -$34.4K | 0.37% | 70 |
|
|
2024
Q1 | $851K | Sell |
1,094
-73
| -6% | -$56.8K | 0.34% | 79 |
|
|
2023
Q4 | $680K | Buy |
1,167
+257
| +28% | +$150K | 0.29% | 94 |
|
|
2023
Q3 | $489K | Sell |
910
-339
| -27% | -$182K | 0.22% | 104 |
|
|
2023
Q2 | $586K | Buy |
1,249
+1
| +0.1% | +$469 | 0.26% | 104 |
|
|
2023
Q1 | $428K | Buy |
1,248
+28
| +2% | +$9.61K | 0.2% | 113 |
|
|
2022
Q4 | $446K | Buy |
+1,220
| New | +$446K | 0.22% | 103 |
|